{To "guide" presupposes that one is in front and up-front. To guide is not to accompany; it is not to follow-up on by bringing-up-the-rear. The fulfillment of these nanotech responsibilities belong not at the back-end but, rather, under the domain of an unrestricted, front-end entity with requisite budget and regulatory powers - neither of which the USFDA fully possesses.} -LLP
US FDA's APRIL 2012 POST-MARKET "GUIDANCE" ON NANOTECHNOLOGIES TO THE FOOD & COSMETICS INDUSTRIES
FORMER FDA DEPUTY COMMISSIONER ON AGENCY'S LACK OF NANO-READINESS {2006}
BEYOND EPHEDERA {LEON JAROFF, TIME MAGAZINE, HEALTH SECTION, 2004}
ARCHIVES OF INTERNAL MEDICINE, VOL. 161, NO. 6 MARCH 2001
NANOTECHNOLOGY IN FOOD PRODUCTS
Comments